ACM
NGM

Aquilo Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Aquilo Capital Management’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,194,237
Closed -$23.6M – 17
2021
Q2 		$23.6M Buy
1,194,237
+70,000
+6% +$1.64M 6.12% 7
2021
Q1 		$32.7M Buy
1,124,237
+118,703
+12% +$3.32M 8.91% 6
2020
Q4 		$30.5M Sell
1,005,534
-12,800
-1% -$280K 9.09% 5
2020
Q3 		$16.2M Sell
1,018,334
-76,850
-7% -$1.4M 6.63% 9
2020
Q2 		$21.6M Buy
1,095,184
+48,000
+5% +$917K 7.95% 8
2020
Q1 		$12.9M Buy
+1,047,184
New +$17.1M 7.21% 8

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return